Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, FL

Clinical Trial Details


Research Study Summary

Alzheimer's Disease


This is a Phase 2, multi-center, double-blind, placebo controlled study to evaluate the safety and efficacy of a study drug in patients with Alzheimer's Disease receiving a stable dose of donepezil. The study will be 26 weeks with 10 office visits. You will be compensated for your time and travel upon completion of study.

Patient Inclusion Criteria

  • Male/female age 50 to 90
  • Must be diagnosed with Alzheimer's Disease
  • Must be on a stable dose of donepezil 10 mg daily for at least 4 months

Patient Exclusion Criteria

  • Neurological exam with focal deficits
  • History or evidence of any CNS disorder that could be interpreted as a cause of dementia,stroke,epilepsy,Parkinson's Disease
  • History of CA within 3 years
  • Use of investigational drug within 30 days of screening

To Learn more

Both Male and Female


50 to 90 Years

Overall Status



26 Weeks

Facility Type



Lisa Dunham, Recruiting
Renstar Medical Research
104 SE 17th St
Ocala, FL 34471
Phone: 352-694-5800 ext. 105

View Map

Research Center Information: Renstar Medical Research

CW ID: 142193

Date Last Changed: July 25, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.